Literature DB >> 19925835

Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes.

Geneviève Gaucher1, Robert H Marchessault, Jean-Christophe Leroux.   

Abstract

Taxanes are potent antimitotic agents that have demonstrated efficacy in a wide range of malignancies. Due to their poor water-solubility, these cytostatic drugs were first formulated with low molecular weight surfactants, e.g. Cremophor EL (CrEL) and Tween 80 (polysorbate 80), which are known to exhibit serious adverse effects in humans. In recent years, there has been growing interest in the design of more biocompatible formulations for both paclitaxel and docetaxel. Polymer-based drug carriers represent an attractive venue given the diversity in the array of existing polymers. Most notably, biopolyesters are vastly employed in the field of biomedical research given their biocompatibility and biodegradability. Polyester-based micelles and nanoparticles have been applied to the parenteral delivery of taxanes with varying degrees of success. Block copolymer micelles possess a unique core-shell structure generated through the self-assembly of amphiphilic copolymers in aqueous media. Although these systems have shown greatly enhanced tolerability compared to formulations based on low molecular weight surfactants, in some cases their failure to retain their cargo following parenteral administration has hindered their capacity to target taxanes to solid tumours. While polyester-based nanoparticles possess comparatively greater stability and drug targeting capacity, they frequently display a significant burst effect whereby a major portion of the cargo is immediately discarded from the carrier upon injection. This review focuses on the current application of polyester-based micelles and nanoparticles to the tumour targeting of taxanes. The preparation, loading efficiencies, release kinetics, cytotoxicity and in vivo behaviour of these systems is discussed in detail. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925835     DOI: 10.1016/j.jconrel.2009.11.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  43 in total

1.  Preferential cellular uptake of amphiphilic macromolecule-lipid complexes with enhanced stability and biocompatibility.

Authors:  Alexander M Harmon; Melissa H Lash; Sarah M Sparks; Kathryn E Uhrich
Journal:  J Control Release       Date:  2011-04-14       Impact factor: 9.776

2.  Nanoparticle shape improves delivery: rational coarse grain molecular dynamics (rCG-MD) of taxol in worm-like PEG-PCL micelles.

Authors:  Sharon M Loverde; Michael L Klein; Dennis E Discher
Journal:  Adv Mater       Date:  2011-11-22       Impact factor: 30.849

Review 3.  Clinical developments in nanotechnology for cancer therapy.

Authors:  Jeremy D Heidel; Mark E Davis
Journal:  Pharm Res       Date:  2010-06-12       Impact factor: 4.200

4.  Block copolymer micelles with acid-labile ortho ester side-chains: Synthesis, characterization, and enhanced drug delivery to human glioma cells.

Authors:  Rupei Tang; Weihang Ji; David Panus; R Noelle Palumbo; Chun Wang
Journal:  J Control Release       Date:  2010-12-29       Impact factor: 9.776

Review 5.  Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.

Authors:  Michele F Oliveira; Pedro P G Guimarães; Alinne D M Gomes; Diego Suárez; Rubén D Sinisterra
Journal:  J Chem Biol       Date:  2012-11-30

Review 6.  Single-chain polymer nanoparticles.

Authors:  Miren Karmele Aiertza; Ibon Odriozola; Germán Cabañero; Hans-Jürgen Grande; Iraida Loinaz
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

Review 7.  Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.

Authors:  Anna Lisa Palange; Roberto Palomba; Ilaria F Rizzuti; Miguel Ferreira; Paolo Decuzzi
Journal:  Mol Ther       Date:  2017-03-22       Impact factor: 11.454

Review 8.  Telodendrimer-based nanocarriers for the treatment of ovarian cancer.

Authors:  Kai Xiao; Nell Suby; Yuanpei Li; Kit S Lam
Journal:  Ther Deliv       Date:  2013-10

9.  Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel.

Authors:  Primiano Pio Di Mauro; Salvador Borrós
Journal:  Pharm Res       Date:  2014-06-18       Impact factor: 4.200

10.  Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.

Authors:  Pu Shi; Suhaas Aluri; Yi-An Lin; Mihir Shah; Maria Edman; Jugal Dhandhukia; Honggang Cui; J Andrew MacKay
Journal:  J Control Release       Date:  2013-05-25       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.